AI Verdict
GILD has stronger fundamentals based on our AI analysis.
EW vs GILD Fundamental Comparison
| Metric | EW | GILD |
|---|---|---|
| Revenue | $1.6B | $7.0B |
| Net Income | $380.7M | $2.0B |
| Net Margin | 23.1% | 29.0% |
| ROE | 3.7% | 8.6% |
| ROA | 2.9% | 3.6% |
| Current Ratio | 4.42x | 1.97x |
| Debt/Equity | 0.06x | 0.94x |
| EPS | $0.66 | $1.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EW vs GILD: Frequently Asked Questions
Is EW or GILD the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. EW is graded C (76% confidence) while GILD is graded A (78% confidence). This is not investment advice.
How does EW compare to GILD fundamentally?
Edwards Lifesciences Corp has ROE of 3.7% vs GILEAD SCIENCES, INC.'s 8.6%. Net margins are 23.1% vs 29.0% respectively.
Which stock pays higher dividends, EW or GILD?
EW has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EW or GILD for long term?
For long-term investing, consider that EW has a C grade with 76% confidence, while GILD has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EW vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EW vs GILD, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.